---
annotations:
- id: PW:0000474
  parent: regulatory pathway
  type: Pathway Ontology
  value: coagulation cascade pathway
authors:
- MaintBot
- Khanspers
- Ariutta
- ReactomeTeam
- Anwesha
- Mkutmon
description: The formation of a fibrin clot at the site of an injury to the wall of
  a normal blood vessel is an essential part of the process to stop blood loss after
  vascular injury.  The reactions that lead to fibrin clot formation are commonly
  described as a cascade, in which the product of each step is an enzyme or cofactor
  needed for following reactions to proceed efficiently.  The entire clotting cascade
  can be divided into three portions, the extrinsic pathway, the intrinsic pathway,
  and the common pathway.  The extrinsic pathway begins with the release of tissue
  factor at the site of vascular injury and leads to the activation of factor X.  The
  intrinsic pathway provides an alternative mechanism for activation of factor X,
  starting from the activation of factor XII.  The common pathway consists of the
  steps linking the activation of factor X to the formation of a multimeric, cross-linked
  fibrin clot.  Each of these pathways includes not only a cascade of events that
  generate the catalytic activities needed for clot formation, but also numerous positive
  and negative regulatory events.  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=140877
  Reactome].
last-edited: 2021-01-25
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP1818
- /instance/WP1818
revision: null
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP1818.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: The formation of a fibrin clot at the site of an injury to the wall
    of a normal blood vessel is an essential part of the process to stop blood loss
    after vascular injury.  The reactions that lead to fibrin clot formation are commonly
    described as a cascade, in which the product of each step is an enzyme or cofactor
    needed for following reactions to proceed efficiently.  The entire clotting cascade
    can be divided into three portions, the extrinsic pathway, the intrinsic pathway,
    and the common pathway.  The extrinsic pathway begins with the release of tissue
    factor at the site of vascular injury and leads to the activation of factor X.  The
    intrinsic pathway provides an alternative mechanism for activation of factor X,
    starting from the activation of factor XII.  The common pathway consists of the
    steps linking the activation of factor X to the formation of a multimeric, cross-linked
    fibrin clot.  Each of these pathways includes not only a cascade of events that
    generate the catalytic activities needed for clot formation, but also numerous
    positive and negative regulatory events.  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=140877
    Reactome].
  keywords:
  - (329-615)
  - (373-615)
  - (compounds)
  - (compounds):IIa
  - (factor
  - (factor IIa)
  - (peptide)
  - (peptide):IIa
  - 10xCbxE-F2(44-327)
  - 10xCbxE-F2(44-622)
  - '10xCbxE-F7(61-212) '
  - '10xCbxE-F7(61-466) '
  - 10xCbxE-F7(61-466):Ca2+
  - '11xCbxE-3D-F10(41-179) '
  - 11xCbxE-PROS1
  - '11xCbxE-PROS1 '
  - '12xCbxE-3D-F9(47-191) '
  - 12xCbxE-3D-F9(47-461)
  - '8xCbxE-3D-PROC(43-197) '
  - A1:A3-C1-C2
  - 'A2M '
  - A2M tetramer
  - Activated protein
  - Activated protein C
  - Bradykinin
  - 'C1QBP '
  - C1q binding protein
  - C:Protein S
  - 'CD177 '
  - Ca2+
  - 'Ca2+ '
  - Extracellular
  - 'F12 T328K '
  - 'F12 T328K (329-615) '
  - 'F12 T328K (373-615) '
  - 'F12 T328K(20-328) '
  - 'F12 T328R '
  - 'F12 T328R (329-615) '
  - 'F12 T328R (373-615) '
  - 'F12 T328R(20-328) '
  - F12 variant
  - F12 variant (20-328)
  - F13B
  - 'F13B '
  - F2R
  - 'F2R '
  - 'F5(29-334) '
  - 'F5(29-534) '
  - F5(335-534)
  - F5(535-737)
  - 'F8(20-355) '
  - 'F8(20-391) A303E '
  - 'F8(20-391) S308L '
  - F8(356-372)
  - 'F8(373-581) '
  - F8(392-759) A2
  - 'F8(392-759) N713I '
  - 'F8(392-759) R550C '
  - 'F8(392-759) R550G '
  - 'F8(392-759) R550H '
  - 'F8(392-759) R717L '
  - 'F8(392-759) R717W '
  - F8(582-640)
  - 'F9(227-461) R384L '
  - F9(29-461)
  - 'FGA '
  - FGA(20-35)
  - 'FGA(20-866) '
  - 'FGB '
  - FGB(31-44)
  - 'FGB(31-491) '
  - 'FGG '
  - FVIIIa:FIXa R384L
  - FVIIIa:FIXa:PROS1
  - Factor IIa
  - Factor VIII
  - Factor Xa inhibitors
  - Fibrinogen
  - GAG
  - 'GAG '
  - 'GP1BA '
  - 'GP1BB '
  - 'GP5 '
  - 'GP9 '
  - GPIb-IX-V
  - IIa):SERPIND1
  - IXa
  - Inactivated factor
  - 'KLKB1(20-390) '
  - KLKB1(20-638)
  - 'KLKB1(20-638) '
  - 'KLKB1(391-638) '
  - 'KNG1(19-380) '
  - KNG1(19-644)
  - 'KNG1(19-644) '
  - 'KNG1(390-644) '
  - KNG:C1q binding
  - NH4+
  - 'PF4(32-101) '
  - 'PF4V1(31-104) '
  - 'PRCP '
  - PROC(200-211)
  - 'PROC(200-461) '
  - 'PROC(212-461) '
  - PROCR
  - 'PROCR '
  - PROCR(18-?)
  - 'PROCR(18-?) '
  - PROCR(18-?):Activated protein C
  - PROCR(18-?):PRTN3:CD177
  - PROCR:Activated
  - PROCR:Protein C
  - 'PRTN3 '
  - PRTN3:CD177
  - PalmC-F3
  - 'PalmC-F3 '
  - Plasma kallikrein
  - Platelet Factor 4
  - Protein C
  - SERPINA5
  - 'SERPINA5 '
  - SERPINA5:Activated
  - SERPINC1
  - 'SERPINC1 '
  - SERPINC1 activators
  - 'SERPINC1(33-425) '
  - 'SERPINC1(426-464) '
  - SERPINC1:SERPINC1
  - SERPIND1
  - 'SERPIND1 '
  - 'SERPINE2 '
  - SERPINE2:GAG
  - SERPINE2:GAG:activated thrombin (factor IIa)
  - SERPING1
  - 'SERPING1 '
  - TF:F7
  - TF:F7a
  - TFPI
  - 'TFPI '
  - TFPI:TF:F7a:factor
  - THBD
  - 'THBD '
  - VIII
  - 'VWF(764-2813) '
  - Va:Xa
  - Va:Xa:Factor Xa
  - Willebrand factor
  - XIa:GPIb:GPIX:GPV
  - Xa
  - Zn2+
  - acidic polypeptide
  - activated
  - activated thrombin
  - activation peptide
  - activators
  - 'apixaban '
  - 'argatroban '
  - binding protein
  - 'bivalirudin '
  - complex
  - complexes
  - crosslinked
  - 'dalteparin '
  - defective A1 domain
  - defective A2 domain
  - domain variant
  - factor
  - factor IX activation
  - factor IXa
  - 'factor IXa heavy chain '
  - factor V
  - factor V activation
  - factor VIII
  - 'factor VIII heavy chain '
  - 'factor VIII light chain '
  - factor VIII:von
  - factor VIIIa
  - factor VIIIa A1
  - 'factor VIIIa A1 polypeptide '
  - factor VIIIa A2
  - 'factor VIIIa A2 polypeptide '
  - 'factor VIIIa A3 C1 C2 polypeptide '
  - factor VIIIa B A3
  - factor VIIIa with
  - factor VIIIa:factor
  - factor VIIa
  - 'factor VIIa heavy chain '
  - factor Va
  - 'factor Va heavy chain '
  - 'factor Va light chain '
  - factor Vi
  - factor X
  - factor X activation
  - 'factor X heavy chain '
  - factor XI
  - 'factor XI monomer '
  - factor XI:GPIb-IX-V
  - factor XII
  - factor XIII
  - factor XIII A chain
  - 'factor XIII A chain '
  - factor XIII cleaved
  - factor XIIIa
  - 'factor XIIIa A chain '
  - factor XIIa
  - 'factor XIIa heavy chain '
  - 'factor XIIa light chain '
  - factor XIIa:C1Inh
  - 'factor XIa heavy chain '
  - 'factor XIa light chain '
  - factor Xa
  - 'factor Xa heavy chain '
  - factor Xa:Factor Xa
  - factor multimer
  - fibrin monomer
  - fibrin multimer
  - fibrin multimer,
  - inactivating
  - inhibitors
  - inhibitors:IIa
  - intermediate form
  - kallikrein:C1Inh
  - kallikrein:alpha2-macroglobulin
  - kallikrein:kininogen:C1q binding protein tetramer
  - kininogen:C1q
  - multimer
  - peptide
  - polypeptide
  - precursor
  - prekallikrein:kininogen:C1q binding protein tetramer
  - prolylcarboxypeptidase dimer
  - protein C
  - protein C:F2R
  - protein tetramer
  - sequestered tissue
  - tetramer
  - thrombin
  - 'thrombin heavy chain '
  - 'thrombin light chain '
  - thrombin:SERPINC1:SERPINC1 activators
  - thrombin:cleaved
  - thrombin:thrombomodulin
  - variant:A3-C1-C2
  - von Willibrand
  license: CC0
  name: Formation of Fibrin Clot (Clotting Cascade)
seo: CreativeWork
title: Formation of Fibrin Clot (Clotting Cascade)
wpid: WP1818
---